Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin add-on to metformin plus glimepiride in type 2 diabetes
2010-021097-11Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin add-on arm with Placebo add-on arm (2 arms). Primary endpoints: Reduction in HbA1c and Reduction in fasting plasma glucose. Started Jul 2010; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-021097-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021097-11.